IDH突变状态与较低级别胶质瘤中不同的血管基因表达特征相关
本研究通过显微切割血管和肿瘤样本基因表达分析、癌症基因组图谱289例较低级别胶质瘤数据、组织芯片免疫组化及体外内皮细胞实验,发现IDH野生型较低级别胶质瘤血管具有独特的血管生成基因表达特征,涉及ANGPT2和SERPINH1上调及TGFβ和缺氧信号增强,IDH野生型与IDH突变型血管分子特征不同。
要点
- WHO II级胶质瘤血管异常程度介于正常血管与胶质母细胞瘤血管之间。
- IDH野生型较低级别胶质瘤血管上调ANGPT2和SERPINH1,与内皮细胞迁移和基质重塑增强相关。
- IDH野生型较低级别胶质瘤中TGFβ和缺氧信号增强,相关基因可被TGFβ2、VEGF或氯化钴诱导。
核心结论
- IDH野生型较低级别胶质瘤血管在分子层面不同于IDH突变型较低级别胶质瘤血管。
- TGFβ和缺氧相关信号通路可能是IDH野生型较低级别胶质瘤抗血管生成治疗的潜在靶点。
研究设计与样本
- 研究分析显微切割血管和肿瘤样本的基因表达,并结合癌症基因组图谱数据库中289例较低级别胶质瘤样本的表达数据。
- 通过人脑肿瘤组织芯片免疫组化检测WHO II-IV级胶质瘤和非恶性脑样本的血管蛋白表达,并在体外原代内皮细胞中检查基因表达调控。
主要发现
- WHO II级胶质瘤基因表达分析显示血管异常处于中间阶段,较胶质母细胞瘤血管轻,但不同于正常血管。
- 人组织芯片染色证实WHO II级胶质瘤中层粘连蛋白亚基α4(LAMA4)和血管生成素2(ANGPT2)表达增强。
- IDH野生型较低级别胶质瘤显示特定血管生成基因表达特征,包括ANGPT2和serpin家族H(SERPINH1)上调,与内皮细胞迁移和基质重塑增强相关。
- 转录因子分析提示IDH野生型较低级别胶质瘤中转化生长因子β(TGFβ)和缺氧信号增强。
- 一部分在IDH野生型较低级别胶质瘤血管中特异性诱导的基因,可在体外被TGFβ2、血管内皮生长因子或氯化钴刺激内皮细胞后上调。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vascular gene expression patterns in lower-grade gliomas (LGGs; diffuse World Health Organization [WHO] grades II-III gliomas) have not been thoroughly investigated. The aim of this study was to molecularly characterize LGG vessels and determine if tumor isocitrate dehydrogenase (IDH) mutation status affects vascular phenotype. METHODS: Gene expression was analyzed using an in-house dataset derived from microdissected vessels and total tumor samples from human glioma in combination with expression data from 289 LGG samples available in the database of The Cancer Genome Atlas. Vascular protein expression was examined by immunohistochemistry in human brain tumor tissue microarrays (TMAs) representing WHO grades II-IV gliomas and nonmalignant brain samples. Regulation of gene expression was examined in primary endothelial cells in vitro. RESULTS: Gene expression analysis of WHO grade II glioma indicated an intermediate stage of vascular abnormality, less severe than that of glioblastoma vessels but distinct from normal vessels. Enhanced expression of laminin subunit alpha 4 (LAMA4) and angiopoietin 2 (ANGPT2) in WHO grade II glioma was confirmed by staining of human TMAs. IDH wild-type LGGs displayed a specific angiogenic gene expression signature, including upregulation of ANGPT2 and serpin family H (SERPINH1), connected to enhanced endothelial cell migration and matrix remodeling. Transcription factor analysis indicated increased transforming growth factor beta (TGFβ) and hypoxia signaling in IDH wild-type LGGs. A subset of genes specifically induced in IDH wild-type LGG vessels was upregulated by stimulation of endothelial cells with TGFβ2, vascular endothelial growth factor, or cobalt chloride in vitro. CONCLUSION: IDH wild-type LGG vessels are molecularly distinct from the vasculature of IDH-mutated LGGs. TGFβ and hypoxia-related signaling pathways may be potential targets for anti-angiogenic therapy of IDH wild-type LGG.
引用
- Zhang L, He L, Lugano R, et al. IDH mutation status is associated with distinct vascular gene expression signatures in lower-grade gliomas. Neuro Oncol. 2018. PMID: 29846705. doi:10.1093/neuonc/noy088
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。